Category Archives: Functional limitations

Senju Pharmaceutical Co., Ltd. et al. v. Lupin Limited et al.

Docket No. 2013-1630 NEWMAN, PLAGER, MOORE March 20, 2015 Brief Summary: DC finding Senju’s reexamined composition and method claims relating to gatifloxacin eye drops with added EDTA would have been obvious affirmed. Summary: This case relates to a generic gatifloxacin … Continue reading

Posted in Functional limitations, Generics / ANDA, Obviousness, Reexamination | Leave a comment

Ferring B.V. v. Watson Labs. and Apotex, Inc. et al.

Docket No. 2014-1416 LOURIE, DYK, REYNA August 22, 2014 Brief Summary: DC decision that Ferring’s claims were not obvious affirmed because “critical dissolution limitations” not taught or suggested by prior art. And infringement by “final, coated commercial…tablets” was not shown. … Continue reading

Posted in Functional limitations, Generics / ANDA, Infringement, Injunction, Obviousness | Leave a comment

Abbvie Deutschland GmbH & Co., KG, et al. v. Janssen Biotech, Inc. and Centocor Biologics, LLC Janssen Biotech, Inc. v. Abvie Deutschland GmbH & Co., KG

Docket Nos. 2013-1338, -1346 LOURIE, O’MALLEY(c), CHEN July 1, 2014 Brief Summary: DC decision invalidating AbbVie’s patents regarding human antibodies for neutralizing human IL-12 affirmed for lack of written description (functional genus claims not supported by representative species). Summary: AbbVie … Continue reading

Posted in Appeal, Functional limitations, Written description | Leave a comment

Bayer Cropscience AG v. Dow Agrosciences LLC

Docket No. 2013-1002 PROST, BRYSON, TARANTO (Circuit Judge) September 3, 2013 Brief summary: Bayer’s functional language was held to limit claims. Summary: Bayer appealed DC finding of no infringement of its US Patent No. 6,153,401 relating to herbicide-resistant plants. The … Continue reading

Posted in Claim Construction, Functional limitations, Written description | Leave a comment

The C.W. Zumbiel Company, Inc. v. David J. Kappos et al.

Docket No. 2011-1332, -1333 (Reexamination No. 95/000,077) PROST (d), MOORE, WALLACH December 27, 2012 Brief summary: Certain claims of patent directed to cartons and boxes for holding containers (e.g., beverage cans) found obvious as predictable variations of or disclosed by … Continue reading

Posted in Functional limitations, Obviousness, Preamble | Leave a comment